资讯
Mumbai, July 15 (UNI) Tesla has formally launched its Indian operations on Tuesday with the inauguration of its first showroom at Mumbai''s premium Bandra Kurla Complex.
尊敬的通讯员: 大家好!自2024年4月1日起,中国民用航空网将开启稿件免审发布权益付费制度。注册通讯员仍可在线发稿,但均将进入待审核状态,经编辑评估新闻属性,择优审核发布。如您需要完成所属单位的宣传发稿任务,欢迎加入”航企专区”计划,专区企业下所有可以保证投稿全部免审发布,详见附件。 欢迎继续投稿,为方便稿件发布,推荐您注册网站账号进行自主发布,邮箱news@ccaonline.cn作为备用投稿 ...
All parties had in-depth exchanges on issues such as deepening the cooperation of media think tanks in the Global South and strengthening the momentum of the Global South to reach a consensus on ...
BEIJING, July 15 (Xinhua) -- Despite rising challenges and external uncertainties, China achieved steady economic growth in ...
Xi made the remarks during his meeting with Russian Foreign Minister Sergey Lavrov in Beijing, calling on both sides to ...
BEIJING, July 15 (Xinhua) — An article by Xi Jinping, general secretary of the Communist Party of China (CPC) Central Committee, on unswervingly advancing high-standard opening-up will be published on ...
RIO DE JANEIRO, July 15 (Xinhua) -- Following are the results of Tuesday's matches in the first leg of the Copa Sudamericana playoff round on Tuesday: ...
Prime Minister Anthony Albanese and China’s Premier Li Qiang in the Great Hall of the People in Beijing, China, Tuesday, July 15, 2025. Anthony Albanese has travelled to China for a six-day visit. (AA ...
NANJING, July 15 (Xinhua) -- The 2025 World Youth Development Forum commenced on Tuesday in Suzhou, east China's Jiangsu ...
U.S. President Donald Trump walks toward the Rose Garden of the White House in Washington, D.C., the United States, on July 15, 2025. Trump announced Tuesday that a 19 percent tariff will be imposed ...
In this photo released by Xinhua News Agency, Chinese President Xi Jinping, right, shakes hands with visiting Australian Prime Minister Anthony Albanese prior to their bilateral meeting at the Great H ...
日前,Corcept Therapeutics已向美国FDA提交其专有选择性皮质醇调节剂relacorilant的新药申请(NDA),用于治疗铂类耐药卵巢癌患者。此外,relacorilant用于治疗内源性高皮质醇症(又称库欣综合征,Cushing’s syndrome)的NDA也正在接受FDA审评。值得一提的是,该疗法获行业媒体Evaluate评选为2025年潜在重磅疗法之一。 该新药申请主要基 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果